Startups  July 9, 2018

Biodesix execs discuss company’s first major acquisition, Indi

Westen Hahn spots a mass spectrometry plate used to generate a VeriStrat result. (Courtesy Biodesix)
By

BOULDER — Biodesix Inc., a Boulder-based biotech firm specializing in blood-based diagnostic tests for lung-disease patients, has acquired Seattle-based Integrated Diagnostics Inc., also known as Indi.

Biodesix, which has offices in Boulder and Steamboat Springs, makes tests that can help physicians determine how a patient will respond to certain lung disease treatment options, given certain protein-based and genomics-based

Tunee Pelletier, a Biodesix employee, holds a blood sample ready to be processed for genomic testing. (Courtesy Biodesix)

signalers in their bloodstream. Indi makes another blood-based diagnostics…

Related Posts

Christopher Wood
Christopher Wood is editor and publisher of BizWest, a regional business journal covering Boulder, Broomfield, Larimer and Weld counties. Wood co-founded the Northern Colorado Business Report in 1995 and served as publisher of the Boulder County Business Report until the two publications were merged to form BizWest in 2014. From 1990 to 1995, Wood served as reporter and managing editor of the Denver Business Journal. He is a Marine Corps veteran and a graduate of the University of Colorado Boulder. He has won numerous awards from the Colorado Press Association, Society of Professional Journalists and the Alliance of Area Business Publishers.
Categories: Boulder Morning Edition Startups Technology Today's News
Sign up for BizWest Daily Alerts